Only a few months after stepping…
Only a few months after stepping into the role of [...]
With more than $1 billion in debt…
With more than $1 billion in debt due in 2027, [...]
Werewolf Therapeutics is…
Werewolf Therapeutics is transforming its brand awareness and clinical trial [...]
The FDA approved Jazz’s Modeyso…
The FDA approved Jazz’s Modeyso (dordaviprone), which was picked up [...]
President Donald Trump has doubled…
President Donald Trump has doubled down on his plan to [...]
As investors and industry watchers…
As investors and industry watchers juggle the twin possibilities of [...]
While the JAK inhibitor market for…
While the JAK inhibitor market for alopecia areata has grown [...]
In his first public appearance as…
In his first public appearance as Incyte’s CEO, Bill Meury [...]
Regeneron is having difficulties…
Regeneron is having difficulties again with its manufacturing partner Novo [...]
As Moderna plows ahead with its…
As Moderna plows ahead with its multiyear cost-savings scheme, the [...]